Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer

BACKGROUND: Second-line (2 L) chemotherapies for advanced or metastatic gastric cancer have shown improved survival but there is no commonly accepted standard of care. This study examines real-world patient characteristics, treatment patterns, healthcare resource use (HCRU) and clinical outcomes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Ulloa, David, Amonkar, Mayur, Kothari, Smita, Cheung, Winson Y., Chau, Ian, Zalcberg, John R., Lara Suriñach, Núria, Falcone, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201990/
https://www.ncbi.nlm.nih.gov/pubmed/32370803
http://dx.doi.org/10.1186/s12876-020-01232-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201990/
https://www.ncbi.nlm.nih.gov/pubmed/32370803
http://dx.doi.org/10.1186/s12876-020-01232-z

Ejemplares similares